MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/pcc.0000000000003642

Медицинская библиотека · Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2024

Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.

McMichael Ali, Weller Jamie, Li Xilong, Hatton Laura, Zia Ayesha, Raman Lakshmi

СтатьяРандомизированное исследованиеСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To test feasibility of a randomized controlled trial (RCT) with an endpoint of time at goal anticoagulation in children on extracorporeal membrane oxygenation (ECMO) randomized to receive bivalirudin vs. unfractionated heparin.

DESIGN

Open-label pilot RCT (NCT03318393) carried out 2018-2021.

SETTING

Single-center quaternary U.S. pediatric hospital.

PATIENTS: Children 0 days to younger than 18 years old supported with ECMO in the PICU or cardiovascular ICU.

INTERVENTIONS: Randomization to bivalirudin vs. unfractionated heparin while on ECMO.

MEASUREMENTS AND MAIN

RESULTS

Sixteen patients were randomized to bivalirudin, and 14 patients were randomized to heparin. There was no difference in the primary outcome, time spent at goal anticoagulation, for patients randomized to bivalirudin compared with those randomized to heparin. While hemorrhagic complications were similar between study groups, thrombotic complications were higher with six of 16 patients in the bivalirudin group having one or more circuit changes compared with 0 of 14 patients in heparin group (mean difference, 37.5% [95% CI, 8.7-61.4%]; p = 0.02). Patients in the bivalirudin group received less packed RBC transfusions vs. those receiving heparin (median [interquartile range], 6.3 mL/kg/d [2.5-8.4 mL/kg/d] vs. 12.2 mL/kg/d [5.5-14.5 mL/kg/d]; p = 0.02).

CONCLUSIONS

In this single-center pilot RCT carried out 2018-2021, we found that the test of anticoagulation therapy of bivalirudin vs. heparin during ECMO was feasible. Larger multicenter studies are required to further assess the safety and efficacy of bivalirudin for pediatric ECMO.

Для цитирования: McMichael Ali, Weller Jamie, Li Xilong, Hatton Laura, Zia Ayesha, Raman Lakshmi. Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2024. DOI: 10.1097/pcc.0000000000003642.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.